Show simple item record

dc.contributor.authorMagoulas, Pilar L.
dc.contributor.authorCorvera, Silvia
dc.contributor.authorFranco, Luis M.
dc.date2022-08-11T08:08:23.000
dc.date.accessioned2022-08-23T15:53:28Z
dc.date.available2022-08-23T15:53:28Z
dc.date.issued2018-05-21
dc.date.submitted2018-07-06
dc.identifier.citation<p>Blood. 2018 May 21. pii: blood-2017-12-824433. doi: 10.1182/blood-2017-12-824433. [Epub ahead of print] <a href="https://doi.org/10.1182/blood-2017-12-824433">Link to article on publisher's site</a></p>
dc.identifier.issn0006-4971 (Linking)
dc.identifier.doi10.1182/blood-2017-12-824433
dc.identifier.pmid29784638
dc.identifier.urihttp://hdl.handle.net/20.500.14038/29360
dc.description<p>Full author list omitted for brevity. For the full list of authors, see article.</p>
dc.description.abstractThe human proteins rabenosyn-5 and VPS45 form a complex that plays a key role in early endocytosis. Pathogenic variants in VPS45 cause severe congenital neutropenia (SCN) with impaired neutrophil function, reticulin fibrosis of the bone marrow, and extramedullary hematopoiesis (OMIM: 615285). Patients with a specific VPS45 variant (p.Glu238Lys) also have intellectual disability and bilateral optic nerve hypoplasia. To date, the only evidence of a potential role for RBSN in human disease is the report of a homozygous missense variant (p.Gly425Arg) in a patient with intellectual disability, seizures, microcephaly, osteopenia, mild reticulin fibrosis of the bone marrow, and transient neutropenia.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=29784638&dopt=Abstract">Link to Article in PubMed</a></p>
dc.rightsCopyright © 2018 American Society of Hematology. Accepted manuscript posted after 12 months as allowed by the publisher's author rights policy at http://www.bloodjournal.org/page/authors/copyright-information.
dc.subjectCell Biology
dc.subjectCellular and Molecular Physiology
dc.subjectCongenital, Hereditary, and Neonatal Diseases and Abnormalities
dc.subjectHematology
dc.subjectHemic and Immune Systems
dc.subjectHemic and Lymphatic Diseases
dc.titleSyndromic congenital myelofibrosis associated with a loss-of-function variant in RBSN
dc.typeAccepted Manuscript
dc.source.journaltitleBlood
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=2599&amp;context=faculty_pubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/faculty_pubs/1589
dc.legacy.embargo2019-05-21T00:00:00-07:00
dc.identifier.contextkey12450410
refterms.dateFOA2022-08-23T15:53:28Z
html.description.abstract<p>The human proteins rabenosyn-5 and VPS45 form a complex that plays a key role in early endocytosis. Pathogenic variants in VPS45 cause severe congenital neutropenia (SCN) with impaired neutrophil function, reticulin fibrosis of the bone marrow, and extramedullary hematopoiesis (OMIM: 615285). Patients with a specific VPS45 variant (p.Glu238Lys) also have intellectual disability and bilateral optic nerve hypoplasia. To date, the only evidence of a potential role for RBSN in human disease is the report of a homozygous missense variant (p.Gly425Arg) in a patient with intellectual disability, seizures, microcephaly, osteopenia, mild reticulin fibrosis of the bone marrow, and transient neutropenia.</p>
dc.identifier.submissionpathfaculty_pubs/1589
dc.contributor.departmentUMass Metabolic Network
dc.contributor.departmentProgram in Molecular Medicine


Files in this item

Thumbnail
Name:
blood_2017_12_824433.full.pdf
Size:
707.8Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record